HLVXHilleVaxHLVX info
$1.86info1.64%24h
Global rank20660
Market cap$90.09M
Change 7d-6.53%
YTD Performance-88.32%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    HilleVax (HLVX) Stock Overview

    HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

    HLVX Stock Information

    Symbol
    HLVX
    Address
    75 State StreetBoston, MA 02109United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.hillevax.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    617 213 5054

    HilleVax (HLVX) Price Chart

    -
    Value:-

    HilleVax Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $1.86
    N/A
    Market Cap
    $90.09M
    N/A
    Shares Outstanding
    48.44M
    N/A
    Employees
    62.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org